查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1949848

2026年全球雙磷酸鹽市場報告

Bisphosphonates Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，雙磷酸鹽市場顯著擴張，從2025年的57億美元成長到2026年的60.3億美元，複合年成長率為5.8%。過去幾年的成長可歸因於人口老化加劇、停經後骨質疏鬆症的盛行率上升、醫生主導的骨骼密度篩檢、醫院進行的骨質疏鬆症管理以及注射用雙磷酸鹽的普及應用。

預計未來幾年雙磷酸鹽市場將穩定成長，到2030年市場規模將達到74.5億美元，複合年成長率（CAGR）為5.4%。預測期內的成長要素包括老年人口的成長、居家骨質疏鬆症照護的普及、對長效製劑的偏好、骨骼健康意識的提高以及學名藥的廣泛應用。預測期內的主要趨勢包括骨質疏鬆症治療需求的不斷成長、長效注射療法的日益普及、非專利雙磷酸鹽的廣泛應用、對骨折預防的日益重視以及綜合骨骼健康療法的推出。

預計未來骨質疏鬆症盛行率的上升將推動雙磷酸鹽市場的發展。骨質疏鬆症是一種使骨骼脆弱易碎、容易發生骨折的疾病。其盛行率上升的主要原因是全球人口老化，而人口老化是由於隨著老齡化骨骼密度自然下降，以及生活方式因素和預防保健不足所致。雙磷酸鹽可透過減緩骨骼分解、增強骨骼和降低骨折風險來幫助治療骨質疏鬆症。例如，根據澳洲骨骼健康研究機構「澳洲健康骨骼」（Healthy Bones Australia）估計，2023年澳洲發生了約193,482例與骨質疏鬆症和骨質缺乏症相關的骨折，預計到2033年，這一數字將成長34%，達到237,632例。因此，骨質疏鬆症盛行率的上升正在推動雙磷酸鹽市場的成長。

預計研究和臨床試驗的增加也將推動雙磷酸鹽市場的成長。臨床試驗是指在人體受試者身上進行的研究，旨在評估新治療方法、藥物和醫療設備的安全性、有效性和潛在副作用。臨床研究的增加主要是由於對創新治療方法的需求不斷成長，以滿足不斷變化的醫療需求並改善患者預後。使用雙磷酸鹽的試驗透過評估其在預防和治療骨質疏鬆症和骨轉移等疾病方面的療效和安全性，為骨骼健康療法的發展做出了貢獻。例如，根據英國製藥工業協會 (ABPI) 的數據，截至 2024 年 12 月，英國由製藥業主導的臨床試驗數量從 2022 年的 411 項增加到 2023 年的 426 項。因此，研究和臨床試驗的增加正在推動雙磷酸鹽市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球雙磷酸鹽市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 永續性、氣候技術和循環經濟
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 對骨質疏鬆症治療的需求不斷成長
    • 擴大長效注射療法的使用
    • 非專利磷酸鹽的擴張
    • 人們越來越重視骨折預防
    • 推出一套全面的骨骼健康方案

第5章 終端用戶產業市場分析

  • 醫院
  • 診所
  • 居家醫療機構
  • 專業骨骼健康中心
  • 藥品零售商

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球雙磷酸鹽市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球雙磷酸鹽市場規模、對比及成長率分析
  • 全球雙磷酸鹽市場表現：規模與成長，2020-2025年
  • 全球雙磷酸鹽市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 按類型
  • 阿崙膦酸鈉、伊班膦酸鈉、利塞膦酸鈉、Zoledronic acid
  • 透過行政途徑
  • 口服，靜脈注射
  • 透過分銷管道
  • 醫院藥局、零售藥局、網路藥局和其他通路
  • 透過使用
  • 骨質疏鬆症、柏哲氏病、骨轉移及其他適應症
  • 最終用戶
  • 醫院、診所、居家醫療機構和零售藥局
  • 按類型細分：阿崙膦酸鈉
  • 口服片劑，每週一次，與維生素D合併使用，非專利名阿崙膦酸鈉
  • 依類型細分：伊班膦酸
  • 口服錠劑、每月一次的口服製劑、靜脈注射劑、非專利伊班膦酸鈉
  • 按類型細分：利塞膦酸鈉
  • 速釋片、緩釋片、每週和每月給藥方案，以及與鈣劑的複方製劑
  • 依類型細分：Zoledronic acid
  • 用於治療腫瘤和骨質疏鬆症的Zoledronic acid（非專利） ：每年靜脈輸註一次。

第10章 區域與國家分析

  • 全球雙磷酸鹽市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球雙磷酸鹽市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 雙磷酸鹽市場：競爭格局與市場佔有率（2024 年）
  • 雙磷酸鹽市場：公司估值矩陣
  • 雙磷酸鹽市場：公司概況
    • Merck & Co. Inc.
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Apotex Inc.

第37章：其他領先和創新企業

  • Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Strides Pharma Science Limited, GSK plc, Viatris Inc., Sandoz, Lupin Limited, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Fresenius Kabi, Alembic Pharmaceuticals Ltd.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 雙磷酸鹽市場展望 2030：蘊藏新機會的國家
  • 雙磷酸鹽市場展望 2030：充滿新機會的細分市場
  • 雙磷酸鹽市場2030年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: PH6MBISP01_G26Q1

Bisphosphonates are a class of medications that prevent bone loss by inhibiting osteoclast activity, making them a primary treatment for osteoporosis and other conditions that weaken bones. They are commonly prescribed to reduce the risk of fractures in individuals with low bone density, Paget's disease, or bone metastases from cancer. These drugs help strengthen bones, increase bone mineral density, and lower the risk of fractures, particularly in postmenopausal women and older adults.

The main types of bisphosphonates include alendronate, ibandronate, risedronate, and zoledronic acid. Alendronate is used to treat and prevent conditions such as osteoporosis and Paget's disease. These medications can be administered orally, intravenously, subcutaneously, intraosseously, or intramuscularly and are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels. Key applications include osteoporosis, Paget's disease, bone metastasis, and more, serving end-users such as hospitals, clinics, homecare settings, and pharmaceutical retailers.

Tariffs have raised production and distribution costs in the bisphosphonates market by increasing prices for imported APIs and injectable drug components. Oral and intravenous bisphosphonate therapies are most impacted, particularly across Asia-Pacific and Europe where pharmaceutical imports are significant. However, tariffs are accelerating regional drug production and generic competition, supporting long-term price stability and treatment access.

The bisphosphonates market research report is one of a series of new reports from The Business Research Company that provides bisphosphonates market statistics, including bisphosphonates industry global market size, regional shares, competitors with a bisphosphonates market share, detailed bisphosphonates market segments, market trends and opportunities, and any further data you may need to thrive in the bisphosphonates industry. This bisphosphonates market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bisphosphonates market size has grown strongly in recent years. It will grow from $5.7 billion in 2025 to $6.03 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to aging population growth, postmenopausal osteoporosis prevalence, physician-led bone density screening, hospital-based osteoporosis management, injectable bisphosphonate adoption.

The bisphosphonates market size is expected to see strong growth in the next few years. It will grow to $7.45 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increase in elderly population, home-based osteoporosis care, long-acting dosage preference, improved bone health awareness, generic drug penetration. Major trends in the forecast period include rising demand for osteoporosis treatments, increased use of long-acting injectable therapies, expansion of generic bisphosphonate drugs, growing focus on fracture prevention, adoption of combination bone health therapies.

The increasing prevalence of osteoporosis is expected to drive the growth of the bisphosphonates market going forward. Osteoporosis is a condition characterized by weakened bones that become fragile and more susceptible to fractures. Its prevalence is rising mainly due to the aging global population, as bone density naturally declines with age, compounded by lifestyle factors and insufficient preventive care. Bisphosphonates help treat osteoporosis by slowing bone breakdown, thereby strengthening bones and reducing fracture risk. For instance, in August 2024, according to Healthy Bones Australia, an Australia-based bone health research organization, there were an estimated 193,482 fractures related to osteoporosis and osteopenia in 2023, projected to increase by 34% to 237,632 fractures by 2033. Therefore, the increasing prevalence of osteoporosis is driving the growth of the bisphosphonates market.

The increase in research and clinical trials is also expected to propel the growth of the bisphosphonates market. Clinical trials are research studies conducted with human participants to assess the safety, efficacy, and potential side effects of new treatments, drugs, or medical devices. The rise in clinical research is primarily driven by the growing demand for innovative therapies to meet evolving healthcare needs and improve patient outcomes. Trials involving bisphosphonates advance bone health therapies by evaluating their effectiveness and safety in preventing and treating conditions such as osteoporosis and bone metastases. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based industry association, industry-initiated clinical trials in the UK increased from 411 in 2022 to 426 in 2023. Therefore, the increase in research and clinical trials is supporting the growth of the bisphosphonates market.

In May 2023, Abiogen Pharma S.p.A., an Italy-based pharmaceutical company, acquired EffRx Pharmaceuticals SA for an undisclosed amount. Through this acquisition, Abiogen aims to strengthen and diversify its rare disease portfolio by integrating EffRx's innovative treatments for musculoskeletal and rare conditions, while expanding its global presence and capabilities in developing and commercializing specialized therapies. EffRx Pharmaceuticals SA, based in Switzerland, manufactures and commercializes bisphosphonates for treating osteoporosis.

Major companies operating in the bisphosphonates market are Merck & Co. Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Strides Pharma Science Limited, GSK plc, Viatris Inc., Sandoz, Lupin Limited, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Fresenius Kabi, Alembic Pharmaceuticals Ltd.

North America was the largest region in the bisphosphonates market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bisphosphonates market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bisphosphonates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bisphosphonates market consists of sales of oral tablets, bisphosphonate capsules, bisphosphonate injections, oral solutions, and intravenous (IV) infusions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bisphosphonates Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses bisphosphonates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bisphosphonates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bisphosphonates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Alendronate; Ibandronate; Risedronate; Zoledronic Acid
  • 2) By Route Of Administration: Oral; Intravenous
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
  • 4) By Application: Osteoporosis; Paget's Disease; Bone Metastasis; Other Application
  • 5) By End-User: Hospitals; Clinics; Homecare Settings; Pharmaceutical Retail
  • Subsegments:
  • 1) By Alendronate: Oral Tablets; Once-Weekly Formulation; Combination With Vitamin D; Generic Alendronate
  • 2) By Ibandronate: Oral Tablets; Monthly Oral Formulation; Intravenous Injection; Generic Ibandronate
  • 3) By Risedronate: Immediate-Release Tablets; Delayed-Release Tablets; Weekly And Monthly Dosing; Combination With Calcium
  • 4) By Zoledronic Acid: Intravenous Infusion; Annual Dosing; Oncology Use; Osteoporosis Use; Generic Zoledronic Acid
  • Companies Mentioned: Merck & Co. Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Apotex Inc.; Aurobindo Pharma Ltd.; Dr. Reddy's Laboratories Ltd.; Cipla Ltd.; Alkem Laboratories; Strides Pharma Science Limited; GSK plc; Viatris Inc.; Sandoz; Lupin Limited; Zydus Lifesciences Ltd.; Torrent Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd.; Hikma Pharmaceuticals PLC; Fresenius Kabi; Alembic Pharmaceuticals Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Bisphosphonates Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Bisphosphonates Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Bisphosphonates Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Bisphosphonates Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Rising Demand For Osteoporosis Treatments
    • 4.2.2 Increased Use Of Long-Acting Injectable Therapies
    • 4.2.3 Expansion Of Generic Bisphosphonate Drugs
    • 4.2.4 Growing Focus On Fracture Prevention
    • 4.2.5 Adoption Of Combination Bone Health Therapies

5. Bisphosphonates Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Homecare Settings
  • 5.4 Specialty Bone Health Centers
  • 5.5 Pharmaceutical Retailers

6. Bisphosphonates Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Bisphosphonates Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Bisphosphonates PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Bisphosphonates Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Bisphosphonates Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Bisphosphonates Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Bisphosphonates Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Bisphosphonates Market Segmentation

  • 9.1. Global Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Alendronate, Ibandronate, Risedronate, Zoledronic Acid
  • 9.2. Global Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral, Intravenous
  • 9.3. Global Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
  • 9.4. Global Bisphosphonates Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Osteoporosis, Paget's Disease, Bone Metastasis, Other Application
  • 9.5. Global Bisphosphonates Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Homecare Settings, Pharmaceutical Retail
  • 9.6. Global Bisphosphonates Market, Sub-Segmentation Of Alendronate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral Tablets, Once-Weekly Formulation, Combination With Vitamin D, Generic Alendronate
  • 9.7. Global Bisphosphonates Market, Sub-Segmentation Of Ibandronate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral Tablets, Monthly Oral Formulation, Intravenous Injection, Generic Ibandronate
  • 9.8. Global Bisphosphonates Market, Sub-Segmentation Of Risedronate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immediate-Release Tablets, Delayed-Release Tablets, Weekly And Monthly Dosing, Combination With Calcium
  • 9.9. Global Bisphosphonates Market, Sub-Segmentation Of Zoledronic Acid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Intravenous Infusion, Annual Dosing, Oncology Use, Osteoporosis Use, Generic Zoledronic Acid

10. Bisphosphonates Market Regional And Country Analysis

  • 10.1. Global Bisphosphonates Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Bisphosphonates Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Bisphosphonates Market

  • 11.1. Asia-Pacific Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Bisphosphonates Market

  • 12.1. China Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Bisphosphonates Market

  • 13.1. India Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Bisphosphonates Market

  • 14.1. Japan Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Bisphosphonates Market

  • 15.1. Australia Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Bisphosphonates Market

  • 16.1. Indonesia Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Bisphosphonates Market

  • 17.1. South Korea Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Bisphosphonates Market

  • 18.1. Taiwan Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Bisphosphonates Market

  • 19.1. South East Asia Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Bisphosphonates Market

  • 20.1. Western Europe Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Bisphosphonates Market

  • 21.1. UK Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Bisphosphonates Market

  • 22.1. Germany Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Bisphosphonates Market

  • 23.1. France Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Bisphosphonates Market

  • 24.1. Italy Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Bisphosphonates Market

  • 25.1. Spain Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Bisphosphonates Market

  • 26.1. Eastern Europe Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Bisphosphonates Market

  • 27.1. Russia Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Bisphosphonates Market

  • 28.1. North America Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Bisphosphonates Market

  • 29.1. USA Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Bisphosphonates Market

  • 30.1. Canada Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Bisphosphonates Market

  • 31.1. South America Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Bisphosphonates Market

  • 32.1. Brazil Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Bisphosphonates Market

  • 33.1. Middle East Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Bisphosphonates Market

  • 34.1. Africa Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Bisphosphonates Market Regulatory and Investment Landscape

36. Bisphosphonates Market Competitive Landscape And Company Profiles

  • 36.1. Bisphosphonates Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Bisphosphonates Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Bisphosphonates Market Company Profiles
    • 36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Bisphosphonates Market Other Major And Innovative Companies

  • Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Strides Pharma Science Limited, GSK plc, Viatris Inc., Sandoz, Lupin Limited, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Fresenius Kabi, Alembic Pharmaceuticals Ltd.

38. Global Bisphosphonates Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Bisphosphonates Market

40. Bisphosphonates Market High Potential Countries, Segments and Strategies

  • 40.1 Bisphosphonates Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Bisphosphonates Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Bisphosphonates Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer